Fabrice Chimienti

Fabrice CHIMIENTI, PhD, is an accomplished scientist with extensive experience in the pharmaceutical and biotech industries. Currently serving as Global Partner Lead in Digital Health Partnerships at Novo Nordisk since August 2020, Fabrice CHIMIENTI previously held significant roles at ALCEDIAG as Principal Scientist and Head of NGS, focusing on diagnostics for mental health using NGS technology. Prior to that, notable contributions were made at AstraZeneca in various capacities from Clinical Scientist to Project Leader, emphasizing pancreatic beta cell health and project management. Earlier career highlights include serving as Chief Scientific Officer at MELLITECH SAS and postdoctoral positions at CEA and CHUV, where key research advancements in pancreatic biology were achieved. Fabrice CHIMIENTI holds a PhD in cellular and molecular biology from Université Paris V and has a foundational education in biotechnology.